To explore the binding target of PPARγ, the methylation levels of CpG sites in the promoter of PPARγ were observed in CX3CR1+ monocytes from both ITP patients and HCs by BSP methods. This evidence concerns the gene CX3CR1 and autoimmune thrombocytopenic purpura.